|
|
regulation of system process
|
GO:0044057 |
200 |
0.576
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.555
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.482
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.469
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.388
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.383
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.358
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.356
|
Mouse |
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.338
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.330
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.302
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.290
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.271
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.270
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.269
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.264
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.248
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.247
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.245
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.244
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.244
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.230
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.207
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.203
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.202
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.198
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.197
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.193
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.192
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.191
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.190
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.187
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.186
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.186
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.186
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.180
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.178
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.173
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.173
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.173
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.169
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.167
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.166
|
Mouse |
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.166
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.165
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.164
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.161
|
Mouse |
|
|
cation transport
|
GO:0006812 |
399 |
0.160
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.155
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.154
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.153
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.152
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.144
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.143
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.142
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.141
|
|
|
|
protein kinase c activating g protein coupled receptor signaling pathway
|
GO:0007205 |
4 |
0.138
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.134
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.127
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.121
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.120
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.118
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.116
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.114
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.114
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.113
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.112
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.111
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.111
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.109
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.107
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.106
|
Mouse |
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.105
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.105
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.105
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.104
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.104
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.101
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.100
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
34 |
0.100
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.099
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.099
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.099
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.097
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.097
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.097
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.097
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.095
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.093
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.092
|
|
|
|
adenylate cyclase activating g protein coupled receptor signaling pathway
|
GO:0007189 |
30 |
0.091
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.088
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.087
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.086
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.086
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.086
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.085
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
7 |
0.084
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.084
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.083
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.082
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.081
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.080
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.080
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.079
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.079
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.078
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.077
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.077
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.076
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.076
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.076
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.075
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.075
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.074
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.074
|
|
|
|
negative regulation of myoblast differentiation
|
GO:0045662 |
18 |
0.074
|
|
|
|
positive regulation of muscle contraction
|
GO:0045933 |
10 |
0.072
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.071
|
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.071
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.070
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.069
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.068
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.067
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.067
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.067
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.066
|
|
|
|
positive regulation of glial cell proliferation
|
GO:0060252 |
4 |
0.066
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.065
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.065
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.064
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.064
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.063
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.063
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.063
|
|
|
|
sarcomere organization
|
GO:0045214 |
24 |
0.063
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.063
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.063
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.063
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.063
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.061
|
|
|
|
regulation of monocyte chemotaxis
|
GO:0090025 |
3 |
0.061
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.061
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.060
|
|
|
|
camp mediated signaling
|
GO:0019933 |
15 |
0.060
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.059
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.059
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.059
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.059
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.059
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.058
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.058
|
|
|
|
striated muscle hypertrophy
|
GO:0014897 |
24 |
0.058
|
Mouse |
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
40 |
0.058
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.058
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.058
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.057
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.057
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.057
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.056
|
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
3 |
0.056
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.055
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.054
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.054
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.054
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.053
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.053
|
|
|
|
camp metabolic process
|
GO:0046058 |
40 |
0.053
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.053
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.053
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.052
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
31 |
0.051
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.051
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.051
|
Mouse |
|
|
immune effector process
|
GO:0002252 |
321 |
0.051
|
|
|
|
intermediate filament cytoskeleton organization
|
GO:0045104 |
26 |
0.051
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.051
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.050
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.050
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.050
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.050
|
|
|
|
phospholipase c activating g protein coupled receptor signaling pathway
|
GO:0007200 |
26 |
0.050
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
31 |
0.050
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.049
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.049
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.049
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.049
|
|
|
|
regulation of thyroid hormone generation
|
GO:2000609 |
4 |
0.049
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.049
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.048
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.048
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.047
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.047
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.047
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.047
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.047
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.047
|
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.046
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.046
|
|
|
|
cervix development
|
GO:0060067 |
2 |
0.046
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.046
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.046
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.045
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.045
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.045
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.045
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.045
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.045
|
|
|
|
regulation of camp metabolic process
|
GO:0030814 |
30 |
0.044
|
|
|
|
mature dendritic cell differentiation
|
GO:0097029 |
3 |
0.044
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.044
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.044
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.044
|
|
|
|
detection of abiotic stimulus
|
GO:0009582 |
60 |
0.044
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.044
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.043
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.043
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.043
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.043
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.043
|
|
|
|
potassium ion transport
|
GO:0006813 |
52 |
0.043
|
|
|
|
regulation of myoblast differentiation
|
GO:0045661 |
29 |
0.043
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.042
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.042
|
|
|
|
cardiac muscle hypertrophy
|
GO:0003300 |
23 |
0.042
|
Mouse |
|
|
neuropeptide signaling pathway
|
GO:0007218 |
19 |
0.042
|
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
34 |
0.042
|
|
|
|
positive regulation of adenylate cyclase activity involved in g protein coupled receptor signaling pathway
|
GO:0010579 |
3 |
0.042
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.042
|
|
|
|
positive regulation of synaptic plasticity
|
GO:0031915 |
4 |
0.042
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.042
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.042
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.042
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.041
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.041
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.040
|
|
|
|
positive regulation of renal sodium excretion
|
GO:0035815 |
2 |
0.040
|
|
|
|
adult walking behavior
|
GO:0007628 |
41 |
0.040
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.040
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.040
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.040
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.040
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.040
|
|
|
|
regulation of striated muscle contraction
|
GO:0006942 |
25 |
0.039
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.039
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.039
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.039
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
56 |
0.039
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.039
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.039
|
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.038
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.038
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.038
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.038
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.038
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.038
|
|
|
|
pigmentation
|
GO:0043473 |
71 |
0.038
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.037
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.037
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.037
|
|
|
|
positive regulation of cyclic nucleotide biosynthetic process
|
GO:0030804 |
24 |
0.037
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.037
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.036
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.036
|
Mouse |
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.036
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.036
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.036
|
|
|
|
cellular response to metal ion
|
GO:0071248 |
31 |
0.036
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.036
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.036
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.036
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.036
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.036
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.036
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.036
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.035
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.035
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.035
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.035
|
|
|
|
release of sequestered calcium ion into cytosol
|
GO:0051209 |
42 |
0.034
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.034
|
|
|
|
heart trabecula formation
|
GO:0060347 |
14 |
0.034
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.034
|
|
|
|
ventricular cardiac muscle cell action potential
|
GO:0086005 |
4 |
0.034
|
|
|
|
positive regulation of camp biosynthetic process
|
GO:0030819 |
19 |
0.034
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.033
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.033
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.033
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.033
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.033
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.033
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.033
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.033
|
|
|
|
regulation of interleukin 5 secretion
|
GO:2000662 |
2 |
0.033
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.033
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.032
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.032
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.032
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.032
|
|
|
|
detection of external stimulus
|
GO:0009581 |
61 |
0.032
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.032
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.032
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.032
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.032
|
|
|
|
regulation of heart rate
|
GO:0002027 |
36 |
0.032
|
|
|
|
positive regulation of heart contraction
|
GO:0045823 |
14 |
0.032
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.032
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.032
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.031
|
|
|
|
regulation of intestinal epithelial structure maintenance
|
GO:0060730 |
1 |
0.031
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.031
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.031
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.031
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.031
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.030
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.030
|
|
|
|
positive regulation of auditory receptor cell differentiation
|
GO:0045609 |
1 |
0.030
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.030
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.030
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.030
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.030
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.030
|
|
|
|
response to pain
|
GO:0048265 |
26 |
0.030
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.030
|
|
|
|
response to estrogen
|
GO:0043627 |
24 |
0.030
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.030
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.029
|
|
|
|
regulation of smooth muscle contraction
|
GO:0006940 |
22 |
0.029
|
|
|
|
regulation of circadian sleep wake cycle sleep
|
GO:0045187 |
3 |
0.029
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.029
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.029
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.029
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.028
|
|
|
|
muscle hypertrophy
|
GO:0014896 |
24 |
0.028
|
Mouse |
|
|
regulation of muscle adaptation
|
GO:0043502 |
31 |
0.028
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.028
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.028
|
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.028
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.028
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.028
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.028
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.028
|
|
|
|
circadian sleep wake cycle rem sleep
|
GO:0042747 |
1 |
0.028
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.028
|
|
|
|
regulation of circadian sleep wake cycle
|
GO:0042749 |
3 |
0.028
|
|
|
|
response to calcium ion
|
GO:0051592 |
20 |
0.028
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.028
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.028
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.028
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.028
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.028
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.028
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.027
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.027
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.027
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.027
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.027
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.027
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.027
|
|
|
|
regulation of cyclic nucleotide biosynthetic process
|
GO:0030802 |
31 |
0.027
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.027
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.027
|
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.027
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.027
|
|
|
|
neuroepithelial cell differentiation
|
GO:0060563 |
37 |
0.027
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.027
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.027
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.027
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.026
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.026
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.026
|
|
|
|
visceral serous pericardium development
|
GO:0061032 |
2 |
0.026
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.026
|
|
|
|
positive regulation of potassium ion transmembrane transport
|
GO:1901381 |
3 |
0.026
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.026
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.026
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.026
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.026
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.025
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.025
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.025
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.025
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.025
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.025
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.025
|
|
|
|
regulation of saliva secretion
|
GO:0046877 |
2 |
0.025
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
51 |
0.025
|
|
|
|
cyclic nucleotide mediated signaling
|
GO:0019935 |
18 |
0.025
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.025
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.025
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.025
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.025
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.025
|
|
|
|
positive regulation of inner ear receptor cell differentiation
|
GO:2000982 |
1 |
0.025
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.024
|
|
|
|
regulation of excretion
|
GO:0044062 |
5 |
0.024
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.024
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.024
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.024
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.024
|
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
26 |
0.024
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.024
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.024
|
|
|
|
positive regulation of potassium ion transport
|
GO:0043268 |
3 |
0.024
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.024
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.023
|
|
|
|
positive regulation of camp metabolic process
|
GO:0030816 |
19 |
0.023
|
|
|
|
peripheral nervous system neuron axonogenesis
|
GO:0048936 |
3 |
0.023
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.023
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.023
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.023
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.023
|
|
|
|
interferon gamma production
|
GO:0032609 |
67 |
0.023
|
|
|
|
positive regulation of urine volume
|
GO:0035810 |
6 |
0.023
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.023
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.023
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.023
|
|
|
|
regulation of adenylate cyclase activity
|
GO:0045761 |
10 |
0.023
|
|
|
|
positive regulation of interferon gamma production
|
GO:0032729 |
39 |
0.023
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.022
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.022
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.022
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.022
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.022
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.022
|
|
|
|
mitotic nuclear division
|
GO:0007067 |
48 |
0.022
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.022
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.022
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.022
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.022
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.022
|
|
|
|
circadian sleep wake cycle
|
GO:0042745 |
5 |
0.022
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.022
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.022
|
|
|
|
interleukin 12 secretion
|
GO:0072610 |
3 |
0.022
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.022
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.022
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.022
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.022
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.021
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.021
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.021
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.021
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.021
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.021
|
|
|
|
response to temperature stimulus
|
GO:0009266 |
55 |
0.021
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.021
|
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
29 |
0.021
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.021
|
|
|
|
apoptotic process involved in morphogenesis
|
GO:0060561 |
25 |
0.021
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.021
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.021
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.021
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.021
|
|
|
|
negative regulation of binding
|
GO:0051100 |
39 |
0.021
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.021
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.021
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.021
|
|
|
|
calcium ion transport into cytosol
|
GO:0060402 |
48 |
0.021
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.020
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.020
|
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.020
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.020
|
|
|
|
regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032434 |
40 |
0.020
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.020
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.020
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation
|
GO:0003257 |
3 |
0.020
|
|
|
|
acid secretion
|
GO:0046717 |
33 |
0.020
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.020
|
|
|
|
tendon formation
|
GO:0035992 |
4 |
0.020
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.020
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.020
|
|
|
|
interleukin 5 secretion
|
GO:0072603 |
2 |
0.020
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.020
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.020
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.020
|
|
|
|
t cell extravasation
|
GO:0072683 |
4 |
0.020
|
|
|
|
metanephric nephron development
|
GO:0072210 |
34 |
0.020
|
|
|
|
regulation of oxidative phosphorylation uncoupler activity
|
GO:2000275 |
3 |
0.020
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.020
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.019
|
|
|
|
positive regulation of nuclear division
|
GO:0051785 |
27 |
0.019
|
|
|
|
astrocyte differentiation
|
GO:0048708 |
43 |
0.019
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.019
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.019
|
|
|
|
cellular response to gonadotropin stimulus
|
GO:0071371 |
4 |
0.019
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.019
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.019
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.019
|
|
